Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 5,404 | 3,835 | 3,982 | 4,912 | 5,101 |
| Cost of Goods | 2,769 | 2,426 | 2,701 | 3,694 | 2,538 |
| Gross Profit | 2,635 | 1,409 | 1,281 | 1,229 | 2,563 |
| Operating Expenses | 4,846 | 4,485 | 5,083 | 5,854 | 4,511 |
| Operating Income | -1,443 | -2,650 | -3,101 | -3,942 | -1,410 |
| Interest Expense | 21 | 23 | 23 | 9 | 6 |
| Other Income | 48 | -57 | 0 | 10 | 0 |
| Pre-tax Income | -1,416 | -2,730 | -3,125 | -3,942 | -1,416 |
| Net Income Continuous | -1,416 | -2,730 | -3,125 | -3,943 | -1,416 |
| Net Income | $-1,416 | $-2,730 | $-3,125 | $-3,943 | $-1,416 |
| EPS Basic Total Ops | -0.05 | -0.11 | -0.14 | -0.20 | -0.07 |
| EPS Basic Continuous Ops | -0.05 | -0.11 | -0.14 | -0.20 | -0.07 |
| EPS Diluted Total Ops | -0.05 | -0.11 | -0.14 | -0.20 | -0.07 |
| EPS Diluted Continuous Ops | -0.05 | -0.11 | -0.14 | -0.20 | -0.07 |
| EBITDA(a) | $-1,325 | $-2,529 | $-2,992 | $-3,838 | $-1,319 |